Latest Global Distribution News

Senetas Corporation reported a substantial $27.8 million net profit for FY2025, driven by the strategic sale of its Votiro business. The company also announced plans for a capital return and a major share consolidation ahead of a promising growth outlook.

Orthocell Ltd reported a record $9.23 million revenue for FY25, driven by strong sales of its nerve repair and dental products, alongside securing US FDA clearance for its flagship nerve repair device Remplir. The company is poised for accelerated growth as it expands its global commercial footprint.

Critica Limited has dispatched an upgraded composite concentrate from its Jupiter Project to ANSTO for independent hydrometallurgical testing, aiming to produce a Mixed Rare Earth Carbonate (MREC). Complementary assessments by Minutech will help optimise processing routes and support upcoming feasibility studies.

Magellan Financial Group reported a solid FY25 with an 8.2% rise in assets under management and a notable surge in strategic partnership income, offsetting a dip in investment management revenue.

Magellan Financial Group reported a 31% drop in net profit after tax for FY25, yet operating profit rose 5%, supported by strategic partnerships and an 8.2% increase in assets under management. The Board declared a special fully franked dividend, signaling confidence in future earnings.

xReality Group delivered a strong Q4 FY25 with $4.7 million in cash receipts, driven by growth in its Operator XR enterprise software and entertainment divisions, alongside a $2 million placement to institutional investors supporting international expansion.

INOVIQ Limited reports breakthrough results for its ovarian cancer screening test achieving perfect early-stage detection, alongside promising advances in its CAR-exosome cancer therapy program.

Genetic Signatures has formed a strategic partnership with Tecan and Repado to develop a fully automated, scalable infectious disease testing platform integrating advanced automation, compliant software, and proprietary assays.

ClearVue Technologies and LandGlass subsidiary LandVac have entered a strategic partnership to co-develop and commercialize advanced solar vacuum insulated glazing products, aiming to revolutionize energy-efficient building materials worldwide.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

Nova Eye Medical has reported a record A$28.8 million in revenues for FY25, driven by strong US sales and sustained growth of its flagship iTrack™ Advance device.

Senetas reports FY2025 sales slightly below last year amid partner integration delays, while progressing with the Votiro business sale and maintaining strong cash reserves.